 Treatment blepharospasm hemifacial spasm botulinum toxin Canadian multicentre study Botulinum exotoxin use Canada efficacy botulinum toxin management patients blepharospasm mean age years patients hemifacial spasm mean age years Canadian ophthalmologic centres total patients blepharospasm patients hemifacial spasm significant relief symptoms former latter usual starting concentrations drug dosages relief duration relief groups patients ineffective treatments subsequent injections Analysis variance linear trend statistics changes mean duration relief first several treatments individual patients group Side effects transient included ptosis exposure keratitis epiphora strabismus